Literature DB >> 8136334

The medical management of masseteric hypertrophy with botulinum toxin type A.

A P Moore1, G D Wood.   

Abstract

We describe the successful outpatient medical treatment of a patient with bilateral masseteric hypertrophy using botulinum toxin type A in a double-blind placebo controlled study. No significant side-effects occurred, and benefit has so far lasted for 6 months.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8136334     DOI： 10.1016/0266-4356(94)90168-6

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN： 0266-4356            Impact factor:   1.651


  16 in total

1.  Botulinum toxin for treatment of masseteric hypertrophy.

Authors:  Andrew Che Fai Hui
Journal:  J Neurol       Date:  2002-03       Impact factor: 4.849

2.  [Chemodenervation with botulinumtoxin in masseteric hypertrophy].

Authors:  R A Mischkowski; M Siessegger; F Lazar; J E Zöller
Journal:  Mund Kiefer Gesichtschir       Date:  2005-03

Review 3.  Botulinum toxin for masseter hypertrophy.

Authors:  Zbys Fedorowicz; Esther J van Zuuren; Jan Schoones
Journal:  Cochrane Database Syst Rev       Date:  2013-09-09

4.  Electromyographic activity of the masseter muscle after radiofrequency therapy in an animal model.

Authors:  Jin-Won Jung; Kyung-Ho Song; Youngjoon Chee; Yong-Wook Jang; An-Sook Kim; Seong-Gon Kim
Journal:  Oral Maxillofac Surg       Date:  2010-03

Review 5.  New Management in Bilateral Masseter Muscle Hypertrophy.

Authors:  Gabriele Bocchialini; Andrea Castellani; Stefano Negrini; Alessandro Rossi
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2016-11-01

6.  Idiopathic masseter muscle hypertrophy.

Authors:  Biruktawit Kebede; Shimalis Megersa
Journal:  Ethiop J Health Sci       Date:  2011-11

7.  Extended effect after a single dose of type A botulinum toxin for asymmetric masseter muscle hypertrophy.

Authors:  Kasturi Bhattacharjee; Manpreet Singh; Harsha Bhattacharjee
Journal:  Indian J Plast Surg       Date:  2015 May-Aug

Review 8.  Botulinum toxin: The Midas touch.

Authors:  P S Shilpa; Rachna Kaul; Nishat Sultana; Suraksha Bhat
Journal:  J Nat Sci Biol Med       Date:  2014-01

9.  Lower facial remodeling with botulinum toxin type A for the treatment of masseter hypertrophy.

Authors:  Fernanda Homem de Mello de Souza Klein; Fabiane Mulinari Brenner; Maurício Shigeru Sato; Fernanda Manfron Batista Rosas Robert; Karin Adriane Helmer
Journal:  An Bras Dermatol       Date:  2014 Nov-Dec       Impact factor: 1.896

10.  Topographic anatomical localization of the motor nerve entry points (MEPs) of the masseter muscle.

Authors:  Istemihan Coban; Kaan Yucel; Yelda Pinar
Journal:  Surg Radiol Anat       Date:  2021-06-09       Impact factor: 1.246
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.